NCT02683473 Measurement of Energy Metabolism in Infants
| NCT ID | NCT02683473 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pennington Biomedical Research Center |
| Condition | Infant Development |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2016-03-16 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2016-03-16 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.
Eligibility Criteria
Inclusion Criteria: * Healthy, full-term infant * Aged 1 month (28 days) to 3 months (12 weeks, 6 days) at the first visit * Exclusively fed breast milk and/or infant formula * Willing to accept doubly-labeled water Exclusion Criteria: * Unable to complete 3 clinic visits within about 14 days at Pennington Biomedical Research Center * Born preterm (\< 37 weeks gestation) * Congenital abnormality or disability * Gastric reflux * Acute illness within 7 days of the study (fever, diarrhea) * Use of medications to treat a chronic condition (does not include use of vitamin supplements or PRN medication for flatulence or reflux such as Pepcid)
Contact & Investigator
Leanne M Redman, Ph.D.
PRINCIPAL INVESTIGATOR
Pennington Biomedical Research Center
Frequently Asked Questions
Who can join the NCT02683473 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 3 Months, studying Infant Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02683473 currently recruiting?
Yes, NCT02683473 is actively recruiting participants. Contact the research team at abby.altazan@pbrc.edu for enrollment information.
Where is the NCT02683473 trial being conducted?
This trial is being conducted at Baton Rouge, United States.
Who is sponsoring the NCT02683473 clinical trial?
NCT02683473 is sponsored by Pennington Biomedical Research Center. The principal investigator is Leanne M Redman, Ph.D. at Pennington Biomedical Research Center. The trial plans to enroll 70 participants.